MCL1 and acute myeloid leukemia: Notably, MCL‐1 is known to play a pivotal role in maintaining oxidative phosphorylation, thereby contributing to venetoclax resistance in AML.[26, 27] Our findings suggest that AURKB induces hypoxic conditions, resulting in decreased MCL‐1 expression.